Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Switchable Fluorophores for Single-Molecule Localization Microscopy. | Chem Rev | 2018 | 30221931 | PubTator, text mining | PubMed |
| The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia. | Neuropharmacology | 2018 | 30201210 | PubTator, text mining | PubMed |
| Genetic Renal Diseases: The Emerging Role of Zebrafish Models. | Cells | 2018 | 30200518 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors. | Trends Pharmacol Sci | 2018 | 30180973 | PubTator, text mining | PubMed |
| Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload. | Int J Nephrol Renovasc Dis | 2018 | 30147354 | PubTator, text mining | PubMed |
| Investigation of interactions between TLR2, MyD88 and TIRAP by bioluminescence resonance energy transfer is hampered by artefacts of protein overexpression. | PLoS One | 2018 | 30138457 | PubTator, text mining | PubMed |
| Sensory Adaptation to Chemical Cues by Vomeronasal Sensory Neurons. | eNeuro | 2018 | 30105301 | PubTator, text mining | PubMed |
| Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis. | J Clin Invest | 2018 | 30102254 | PubTator, text mining | PubMed |
| Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the AVPR2 Mutations. | Case Rep Pediatr | 2018 | 30073107 | PubTator, text mining | PubMed |
| Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. | Cardiovasc Diabetol | 2018 | 30071874 | PubTator, text mining | PubMed |
| Chemical validation and optimization of pharmacoperones targeting vasopressin type 2 receptor mutant. | Biochem J | 2018 | 30068530 | PubTator, text mining | PubMed |
| Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise. | Am Heart J | 2018 | 30057012 | PubTator, text mining | PubMed |
| Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias. | Hum Mol Genet | 2018 | 30052933 | PubTator, text mining | PubMed |
| Opportunities and Challenges for Genetic Studies of End-Stage Renal Disease in Canada. | Can J Kidney Health Dis | 2018 | 30046452 | PubTator, text mining | PubMed |
| Human β3-Adrenoreceptor is Resistant to Agonist-Induced Desensitization in Renal Epithelial Cells. | Cell Physiol Biochem | 2018 | 30032151 | PubTator, text mining | PubMed |
| Soluble (pro)renin receptor as a potential therapy for diabetes insipidus. | Am J Physiol Renal Physiol | 2018 | 30019932 | PubTator, text mining | PubMed |
| Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy. | Biomed Res Int | 2018 | 30013980 | PubTator, text mining | PubMed |
| Management of refractory cirrhotic ascites: challenges and solutions. | Hepat Med | 2018 | 30013405 | PubTator, text mining | PubMed |
| Phenotype heterogeneity of congenital adrenal hyperplasia due to genetic mosaicism and concomitant nephrogenic diabetes insipidus in a sibling. | BMC Med Genet | 2018 | 29996815 | PubTator, text mining | PubMed |
| A Novel Mutation in the AVPR2 Gene Causing Congenital Nephrogenic Diabetes Insipidus | J Clin Res Pediatr Endocrinol | 2018 | 29991464 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=66